These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 3454353

  • 41. [Clinico-laboratory indices of children revaccinated against measles].
    Sorokina EA, Bystriakova LV, Sertakova ZL, Terekhova LE.
    Tr Inst Im Pastera; 1985; 62():50-4. PubMed ID: 2954276
    [No Abstract] [Full Text] [Related]

  • 42. [Nature of measles virus antibodies in systemic lupus erythematosus].
    Alekberova ZS, Karaseva IA.
    Sov Med; 1980; (9):37-9. PubMed ID: 7423262
    [No Abstract] [Full Text] [Related]

  • 43. Enzyme immunoassay--a method of serological survey of measles vaccination.
    Vedunova SL, Mikheeva IV, Maltseva NN.
    Acta Virol; 1990 Feb; 34(1):95-8. PubMed ID: 1975731
    [Abstract] [Full Text] [Related]

  • 44. [Anti-measles humoral immunity in children with thymus hyperplasia].
    Gurvich EB, Lysenkova NV, Shishatskaia SN, Vaganov PD, Ozeretskovskiĭ NA.
    Pediatriia; 1989 Feb; (9):31-3. PubMed ID: 2587164
    [Abstract] [Full Text] [Related]

  • 45. [Immunologic evaluation of measles vaccine in preschool and school children].
    Soto C, Cordero J, Vergara MI.
    Rev Chil Pediatr; 1981 Feb; 52(6):491-5. PubMed ID: 7347862
    [No Abstract] [Full Text] [Related]

  • 46. [Control over the postvaccinal measles immunity status using the indirect hemagglutination test with lyophilized diagnostic agents].
    Sokhin AA, Sliuar' LI, Smorodinova IP, Rodomskaia FS, Makarova EN.
    Tr Inst Im Pastera; 1981 Feb; 56():121-3. PubMed ID: 7187542
    [No Abstract] [Full Text] [Related]

  • 47. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S, Morishima T, Nishikawa K, Hanada N, Rahman M, Terashima M, Kido S, Ueda S, Takahashi M.
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [Abstract] [Full Text] [Related]

  • 48. Optimum age for measles immunization in Malaysia.
    Chen ST, Lam SK.
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):493-9. PubMed ID: 4095612
    [Abstract] [Full Text] [Related]

  • 49. An assessment of the effectiveness of the measles immunization programme in Lagos, Nigeria.
    Ogunmekan DA, Bracken P, Marshall WC.
    Ann Trop Med Parasitol; 1981 Feb; 75(1):87-92. PubMed ID: 7271359
    [No Abstract] [Full Text] [Related]

  • 50. Maternally derived measles immunity in children of naturally infected and vaccinated mothers.
    Jenks PJ, Caul EO, Roome AP.
    Epidemiol Infect; 1988 Oct; 101(2):473-6. PubMed ID: 3053223
    [Abstract] [Full Text] [Related]

  • 51. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS, Hutchins SS, Thomas A, Williams I, Bellini WJ, Redd SC.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [Abstract] [Full Text] [Related]

  • 52. Measles vaccination. Serologic response and persistence of antibody titer by age at vaccination.
    Biberi-Moroeanu S, Munţiu A, Tiţeica M.
    Arch Roum Pathol Exp Microbiol; 1982 May 01; 41(4):347-55. PubMed ID: 7171306
    [No Abstract] [Full Text] [Related]

  • 53. Comparison between haemagglutination inhibition test and enzyme immunoassay for evaluation of measles immune status and seroconversion to measles vaccine.
    Gebreselassie L, Melamed MD.
    Ethiop Med J; 1983 Jul 01; 21(3):139-42. PubMed ID: 6349985
    [No Abstract] [Full Text] [Related]

  • 54. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M.
    An Esp Pediatr; 1987 Jul 01; 27(1):27-31. PubMed ID: 3662251
    [Abstract] [Full Text] [Related]

  • 55. Ineffectiveness of historical data in predicting measles susceptibility.
    Scott RM, Butler AB, Schydlower M, Rawlings P.
    Pediatrics; 1984 Jun 01; 73(6):777-80. PubMed ID: 6728580
    [Abstract] [Full Text] [Related]

  • 56. Measles immunisation in Thai children aged nine to 14 months.
    Lumbiganon P, Sookpranee T, Tattawasart U, Sukprasert S, Paholpak S.
    Asia Pac J Public Health; 1988 Jun 01; 2(4):241-4. PubMed ID: 3179106
    [No Abstract] [Full Text] [Related]

  • 57. [The role of consultative offices on immunoprophylaxis in organizing epidemiologic surveillance of measles].
    Ignatov SA, Radomskaia FS, Makarova EN, Leĭko AP, Itkina EN, Komarevskaia RV.
    Vrach Delo; 1990 Jan 01; (1):121-3. PubMed ID: 2330697
    [No Abstract] [Full Text] [Related]

  • 58. [Current problems in measles. II. Measles vaccines--recent progress].
    Ciufecu E.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984 Jan 01; 29(3):259-78. PubMed ID: 6438773
    [No Abstract] [Full Text] [Related]

  • 59. Vaccination of seropositive children against measles in Tanzania: boosting of antibody titres or a statistical artifact.
    Mandara MP, Remme J.
    East Afr Med J; 1985 Jan 01; 62(1):12-20. PubMed ID: 4006810
    [No Abstract] [Full Text] [Related]

  • 60. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.
    Just M, Berger R, Glück R, Wegmann A.
    Dev Biol Stand; 1986 Jan 01; 65():25-7. PubMed ID: 3549399
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.